Abstract
Objective
To determine the duration of protection conferred by the hepatitis B (HB) vaccination and the necessity of a booster dose.
Methods
Immediately after the initial blood sampling, 252 youths (aged 18.8-20.5 years, 52% females) with a history of neonatal HB vaccination with one dose of the HB vaccine received a booster. Serum concentrations of antibodies against the HB surface antigen were assessed in samples collected before and 10-14 days after the booster. Seroconversion from concentrations <10 to ≥10 IU/L were defined as a positive immune response.
Results
Of the 252 participants, 131 were serosusceptible and 114 responded.
Conclusions
Nearly 90% of young people preserved their long-term protection; the results of this study do not support the use of an HB booster vaccination.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Poovorawan Y, Chongsrisawat V, Theamboonlers A, Leroux-Roels G, Kuriyakose S, Leyssen M, et al. Evidence of protection against clinical and chronic hepatitis B infection 20 years after infant vaccination in a high endemicity region. J Viral Hepat. 2011;18:369–75.
McMahon BJ, Dentinger CM, Bruden D, Zanis C, Peters H, Hurlburt D, et al. Antibody levels and protection after hepatitis B vaccine: Results of a 22-year follow-up study and response to a booster dose. J Infect Dis. 2009;200:1390–6.
Wu Q, Zhuang GH, Wang XL, Wang LR, Li N, Zhang M. Antibody levels and immune memory 23 years after primary plasma-derived hepatitis B vaccination: results of a randomized placebo-controlled trial cohort from China where endemicity is high. Vaccine. 2011;29:2302–7.
Middleman AB, Baker CJ, Kozinetz CA, Kamili S, Nguyen C, Hu DJ, et al. Duration of protection after infant hepatitis B vaccination series. Pediatrics. 2014;133:e1500–7.
Hammitt LL, Hennessy TW, Fiore AE, Zanis C, Hummel KB, Dunaway E, et al. Hepatitis B immunity in children vaccinated with recombinant hepatitis B vaccine beginning at birth: A follow-up study at 15 years. Vaccine. 2007;25:6958–64.
Chan PK, Ngai KL, Lao TT, Wong MC, Cheung T, Yeung AC, et al. Response to booster doses of hepatitis B vaccine among young adults who had received neonatal vaccination. PLoS One. 2014;9:e107163.
Jan CF, Huang KC, Chien YC, Greydanus DE, Davies HD, Chiu TY, et al. Determination of immune memory to hepatitis B vaccination through early booster response in college students. Hepatology. 2010;51:1547–54.
Pichichero ME. Booster vaccinations: Can immunologic memory outpace disease pathogenesis? Pediatrics. 2009;124:1633–41.
Leuridan E, Van Damme P. Hepatitis B and the need for a booster dose. Clin Infect Dis. 2011;53:68–75.
FitzSimons D, Hendrickx G, Vorsters A, Van Damme P. Hepatitis B vaccination: A completed schedule enough to control HBV lifelong? Vaccine. 2013;31:584–90.
World Health Organization. Hepatitis B Vaccine. WHO position paper. Wkly Epidemiol Rec. 2009;48:405–20.
Saffar H, Ajami A, Saffar MJ, Shojaei J, Sotudeh-Anvari M, Shams-Esfandabad K, et al. Prevalence of hepatitis B virus seromarkers in young adults vaccinated at birth: Impact on the epidemiology of hepatitis B infection in iran. Hepat Mon. 2014;14:e17263.
Saffar MJI, Rezai MS. Long-term antibody response and immunologic memory in children immunized with hepatitis B vaccine at birth. Indian Pediatr. 2004;41:1232–7.
Spradling PR, Xing J, Williams R, Masunu-Faleafaga Y, Dulski T, Mahamud A, et al. Immunity to hepatitis B virus (HBV) infection two decades after implementation of universal infant HBV vaccination: Association of detectable residual antibodies and response to a single HBV challenge dose. Clin Vaccine Immunol. 2013;20:559–61.
Poorolajal J, Mahmoodi M, Majdzadeh R, Nasseri-Moghaddam S, Haghdoost A, Fotouhi A. Long-term protection provided by hepatitis B vaccine and need for booster dose: A meta-analysis. Vaccine. 2010;28:623–31.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made.
The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.
To view a copy of this licence, visit https://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Saffar, H., Khalilian, AR., Saffar, MJ. et al. Long-term Protection Against the Hepatitis B Virus Detected Through an Early Response to a Booster Dose Injection. Indian Pediatr 55, 45–47 (2018). https://doi.org/10.1007/s13312-018-1227-2
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13312-018-1227-2